Landeck, Lilla
Asadullah, Khusru
Amasuno, Adriana
Pau-Charles, Ignasi
Mrowietz, Ulrich
Funding for this research was provided by:
Almirall S.A.
Article History
Received: 10 August 2017
Revised: 13 February 2018
Accepted: 7 March 2018
First Online: 24 March 2018
Compliance with ethical standards
:
: LL has no conflicts of interest to declare. KA is a stock holder and former employee of Bayer AG and has received financial support and/or served as consultant, advisory board member, or speaker for AbbVie, Antabio, Almirall, EmertiPharma, Galderma, Leo, Loreal, Eli Lilly, and Novartis. IPC and AA are employees of Almirall S.A. UM has been an advisor and/or received speakers honoraria and/or received grants and/or participated in clinical trials of the following companies: AbbVie, Almirall, Amgen, Biogen, Boehringer-Ingelheim, Celgene, Dr. Reddy’s, Eli Lilly, Foamix, Formycon, Forward Pharma, Janssen, Leo Pharma, Medac, MSD, Novartis, VBL and Xenoport.
: This article does not contain any studies with human participants or animals performed by any of the authors.